MedTrace Logo

PL_GNT01_ISR_Grant 53234273

NCT06714019 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-12-03

No results posted yet for this study

Summary

We carry out a prospective non-interventional, longitudinal, observational multicentre registry designed to improve our understanding of the epidemiology of TTR amyloidosis in our country. The main objective of the proposed study is to determine the occurrence of TTR amyloidosis and describe clinical profile of patients in the population of our country.

Conditions

  • Transthyretin Cardiomyopathy (TTR-CM)
  • Transthyretin (TTR) Amyloid Cardiomyopathy
  • Transthyretin Amyloidosis

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-11
Primary Completion
2025-10-31
Completion
2025-11-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06714019 on ClinicalTrials.gov